Mon, September 30, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Silvan Tuerkcan Reiterated (BNTC) at Buy and Held Target at $16 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Raghuram Selvaraju Initiated (BLFS) at Strong Buy and Held Target at $29 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Jaeson Schmidt Maintained (BKSY) at Strong Buy with Increased Target to $32 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Chris Quintero Upgraded (BL) to Buy and Increased Target to $70 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Deepak Mathivanan Reiterated (BKNG) at Hold on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Betsy Graseck Maintained (BK) at Hold with Increased Target to $78 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Anthony Linton Maintained (BIP) at Strong Buy with Increased Target to $39 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Eric Beder Reiterated (BBW) at Strong Buy and Held Target at $41 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
William Grippin Upgraded (BEP) to Strong Buy and Increased Target to $31 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Lauren Lieberman Upgraded (BF) to Buy and Increased Target to $53 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Alexander Blostein Maintained (BEN) at Strong Sell with Decreased Target to $21 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Jason Tilchen Maintained (BOWL) at Strong Buy and Held Target at $18 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Doug Schenkel Downgraded (BRKR) to Hold on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Raghuram Selvaraju Reiterated (BBIO) at Strong Buy and Held Target at $43 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Alexander Blostein Maintained (BAM) at Strong Buy with Increased Target to $52 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Betsy Graseck Maintained (BAC) at Buy with Decreased Target to $47 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Michael Baker Maintained (AZO) at Hold on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Donald Fandetti Maintained (AXP) at Buy with Increased Target to $300 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Stephen Richardson Maintained (APA) at Hold with Decreased Target to $33 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Neal Dingmann Maintained (APA) at Strong Buy with Decreased Target to $34 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Jason Kolbert Maintained (ANIX) at Strong Buy and Held Target at $10 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Deepak Mathivanan Reiterated (AMZN) at Buy and Held Target at $230 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Youssef Squali Maintained (AMZN) at Strong Buy with Increased Target to $265 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Russell Gunther Upgraded (AMTB) to Buy and Increased Target to $25 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Stephen Scouten Upgraded (AMTB) to Buy and Increased Target to $27 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Justin Clare Reiterated (AMSC) at Strong Buy and Held Target at $29 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Michael Baker Maintained (AMRK) at Strong Buy with Increased Target to $52 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Kyle Peterson Reiterated (ALIT) at Strong Buy and Held Target at $9 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Keith Weiss Reiterated (ADSK) at Buy and Held Target at $320 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Deepak Mathivanan Reiterated (ABNB) at Sell and Held Target at $94 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Andres Sheppard Reiterated (ACHR) at Buy and Held Target at $10 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Andrew Mok Maintained (ACHC) at Buy with Decreased Target to $76 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Edward White Reiterated (ACET) at Hold on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Ramsey El-Assal Maintained (ACN) at Buy with Increased Target to $415 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Bryan Bergin Upgraded (ACN) to Strong Buy and Increased Target to $400 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
George Gianarikas Maintained (AUR) at Strong Buy and Held Target at $7 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Peter Benedict Maintained (WMT) at Buy with Increased Target to $90 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Michael Shlisky Maintained (WNC) at Hold and Held Target at $18 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Betsy Graseck Maintained (WFC) at Buy with Decreased Target to $67 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Deepak Mathivanan Reiterated (WIX) at Buy and Held Target at $200 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Michael Leithead Upgraded (WLK) to Buy and Increased Target to $180 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Zach Cummins Maintained (ZETA) at Strong Buy with Increased Target to $37 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Ryan MacDonald Maintained (ZETA) at Strong Buy with Increased Target to $36 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Deepak Mathivanan Reiterated (ZG) at Hold and Held Target at $47 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Deepak Mathivanan Reiterated (Z) at Hold and Held Target at $47 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Ken Zerbe Upgraded (ZION) to Hold and Held Target at $54 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Xiaodan Zhang Initiated (zkh) at Buy and Held Target at $4 on, Sep 30th, 2024
[ Mon, Sep 30th 2024 ]: WOPRAI
Oren Livnat Reiterated (zvra) at Strong Buy and Held Target at $20 on, Sep 30th, 2024

Roanna Ruiz Reiterated (AQST) at Buy with Increased Target to $12 on, Sep 30th, 2024

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-12-on-sep-30th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Roanna Ruiz of Leerink Partners, Reiterated "Aquestive Therapeutics, Inc." (AQST) at Buy with Increased Target from $10 to $12 on, Sep 30th, 2024.

Roanna, nor any peers, have made any analyst calls on AQST in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30